Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SHE:300937)
China
· Delayed Price · Currency is CNY 28.55
+0.66 (2.37%)
At close: Apr 29, 2026
SHE:300937 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 2,731 | 3,261 | 2,394 | 3,009 | 2,761 | 4,358 | Upgrade
|
| Market Cap Growth | 8.80% | 36.25% | -20.45% | 8.97% | -36.64% | - | Upgrade
|
| Enterprise Value | 2,638 | 3,264 | 2,406 | 2,978 | 2,728 | 4,281 | Upgrade
|
| Last Close Price | 28.55 | 34.09 | 24.93 | 31.03 | 28.29 | 44.66 | Upgrade
|
| PE Ratio | - | - | 146.32 | 50.54 | 65.71 | 680.87 | Upgrade
|
| PS Ratio | 0.61 | 0.73 | 0.55 | 0.68 | 0.70 | 1.28 | Upgrade
|
| PB Ratio | 3.42 | 4.08 | 2.81 | 3.52 | 3.37 | 5.53 | Upgrade
|
| P/TBV Ratio | 3.57 | 4.27 | 3.05 | 3.80 | 3.70 | 5.98 | Upgrade
|
| P/FCF Ratio | - | - | 25.07 | - | 20.55 | - | Upgrade
|
| P/OCF Ratio | - | - | 18.75 | - | 18.09 | - | Upgrade
|
| EV/Sales Ratio | 0.59 | 0.73 | 0.55 | 0.67 | 0.69 | 1.26 | Upgrade
|
| EV/EBITDA Ratio | 39.69 | 49.80 | 49.75 | 32.01 | 35.22 | 320.29 | Upgrade
|
| EV/EBIT Ratio | 59.61 | 73.78 | 82.52 | 40.26 | 46.88 | 117838.91 | Upgrade
|
| EV/FCF Ratio | -126.82 | - | 25.20 | - | 20.31 | - | Upgrade
|
| Debt / Equity Ratio | 0.42 | 0.42 | 0.46 | 0.39 | 0.30 | 0.17 | Upgrade
|
| Debt / EBITDA Ratio | 5.08 | 5.08 | 6.60 | 3.35 | 2.97 | 7.81 | Upgrade
|
| Debt / FCF Ratio | - | - | 4.07 | - | 1.81 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.09 | -0.09 | 0.00 | -0.06 | -0.27 | -0.03 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.09 | -1.09 | -0.07 | -0.54 | -2.86 | -1.79 | Upgrade
|
| Net Debt / FCF Ratio | 3.44 | 3.44 | -0.04 | 0.33 | -1.65 | 0.13 | Upgrade
|
| Asset Turnover | 2.59 | 2.59 | 2.57 | 2.70 | 2.86 | 3.36 | Upgrade
|
| Inventory Turnover | 7.31 | 7.31 | 7.42 | 8.08 | 8.01 | 7.99 | Upgrade
|
| Quick Ratio | 0.72 | 0.72 | 0.87 | 0.80 | 0.83 | 0.63 | Upgrade
|
| Current Ratio | 1.55 | 1.55 | 1.65 | 1.72 | 1.68 | 2.20 | Upgrade
|
| Return on Equity (ROE) | -1.99% | -1.99% | 1.80% | 6.78% | 4.50% | 1.03% | Upgrade
|
| Return on Assets (ROA) | 1.61% | 1.61% | 1.07% | 2.82% | 2.62% | 0.00% | Upgrade
|
| Return on Invested Capital (ROIC) | -12.99% | -12.89% | 3.16% | 8.56% | 6.88% | 0.01% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.40% | 5.40% | 3.30% | 8.30% | 6.90% | 0.00% | Upgrade
|
| Earnings Yield | -0.47% | -0.39% | 0.68% | 1.98% | 1.52% | 0.15% | Upgrade
|
| FCF Yield | -0.76% | -0.64% | 3.99% | -5.01% | 4.87% | -4.26% | Upgrade
|
| Dividend Yield | 0.36% | - | 0.40% | 0.71% | 0.71% | - | Upgrade
|
| Payout Ratio | - | - | 184.93% | 40.51% | 12.63% | 322.93% | Upgrade
|
| Buyback Yield / Dilution | -0.04% | 0.55% | -0.21% | -0.56% | -4.44% | -26.94% | Upgrade
|
| Total Shareholder Return | 0.31% | 0.55% | 0.19% | 0.15% | -3.73% | -26.94% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.